Pharmaceutical Division, Pharmaceutical Company, Kracie, Ltd, Tokyo, Japan.
Real World Evidence Division, JMDC Inc, Tokyo, Japan.
Int J Chron Obstruct Pulmon Dis. 2024 May 7;19:1011-1019. doi: 10.2147/COPD.S450270. eCollection 2024.
The prevalence of airflow obstruction in Japan is 3.8%-16.9%. This epidemiological study based on a large database aimed to reassess the prevalence of airflow obstruction in Japan and the diagnosis rate of chronic obstructive pulmonary disease (COPD).
We used data regarding claims from the health insurance union and health checkups provided by JMDC. The present study included a subgroup of individuals aged ≥40 years who underwent health checkups involving spirometry between January and December 2019. The study endpoints were the prevalence of airflow obstruction, COPD diagnosis rate, disease stage, and respiratory function test results.
Among 102,190 participants, 4113 (4.0%) had airflow obstruction. The prevalence of airflow obstruction was 5.3% in men and 2.1% in women. Among the study population, 6.8% were current smokers, while 3.4% were never or former smokers. Additionally, the prevalence of COPD increased with age. Approximately 8.4% of participants with airflow obstruction were diagnosed with COPD. Regarding the COPD diagnosis status, participants with airflow obstruction who were diagnosed with COPD were at a more advanced stage than those not diagnosed. Finally, patients diagnosed with COPD had significantly lower FEV/FVC and FEV (p < 0.0001; Wilcoxon rank sum test).
The epidemiological study based on a large database determined the COPD diagnosis rate related to airflow obstruction. The COPD diagnosis rate was extremely low among individuals who underwent health checkups, indicating the need for increased awareness about this medical condition. Moreover, primary care physicians should identify patients with suspected COPD and collaborate with pulmonologists to facilitate the early detection of COPD and enhance the COPD diagnosis rate.
日本的气流阻塞患病率为 3.8%-16.9%。本项基于大型数据库的流行病学研究旨在重新评估日本气流阻塞的患病率和慢性阻塞性肺疾病(COPD)的诊断率。
我们使用了来自健康保险联盟的理赔数据和 JMDC 提供的健康检查数据。本研究纳入了年龄≥40 岁、在 2019 年 1 月至 12 月期间接受包含肺功能检查的健康检查的人群亚组。本研究的终点为气流阻塞的患病率、COPD 的诊断率、疾病分期和呼吸功能检查结果。
在 102190 名参与者中,有 4113 人(4.0%)患有气流阻塞。男性气流阻塞的患病率为 5.3%,女性为 2.1%。研究人群中,6.8%为当前吸烟者,3.4%为从不吸烟者或曾经吸烟者。此外,COPD 的患病率随年龄增长而增加。约 8.4%的气流阻塞患者被诊断为 COPD。关于 COPD 的诊断情况,患有气流阻塞且被诊断为 COPD 的患者比未被诊断为 COPD 的患者处于更晚期。最后,被诊断为 COPD 的患者的 FEV/FVC 和 FEV 值明显更低(p<0.0001;Wilcoxon 秩和检验)。
本项基于大型数据库的流行病学研究确定了与气流阻塞相关的 COPD 诊断率。在接受健康检查的人群中,COPD 的诊断率极低,表明需要提高对这种疾病的认识。此外,初级保健医生应识别出疑似 COPD 的患者,并与肺病专家合作,以促进 COPD 的早期发现并提高 COPD 的诊断率。